Astellas to shell out $3 billion in gene therapy takeover

Japan-based Astellas Pharma is dropping nearly $3 billion in cash to scoop up San Francisco ’s Audentes Therapeutics.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news